基因工程诱导胎儿样造血干细胞。

Gene technology Pub Date : 2020-01-01

Bariş Ulum, Stefan A Muljo

{"title":"基因工程诱导胎儿样造血干细胞。","authors":"Bariş Ulum, Stefan A Muljo","doi":"","DOIUrl":null,"url":null,"abstract":"Bone marrow transplantation (BMT) or hematopoietic stem cell transplantation (HSCT) is an archetype of cellular therapy. However, to date BMT still suffers from several complications. Recent technological advances have encouraged us to think about an alternative to traditional BMT. Specifically, we propose in utero HSCT (IUHSCT). For this purpose, we suggest that induced fetal-like hematopoietic stem cells (ifHSCs) might be suitable for IUHSCT, and should be seriously evaluated.","PeriodicalId":90831,"journal":{"name":"Gene technology","volume":"9 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470128/pdf/","citationCount":"0","resultStr":"{\"title\":\"Genetic Engineering to Induce Fetal-Like Hematopoietic Stem Cells.\",\"authors\":\"Bariş Ulum, Stefan A Muljo\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Bone marrow transplantation (BMT) or hematopoietic stem cell transplantation (HSCT) is an archetype of cellular therapy. However, to date BMT still suffers from several complications. Recent technological advances have encouraged us to think about an alternative to traditional BMT. Specifically, we propose in utero HSCT (IUHSCT). For this purpose, we suggest that induced fetal-like hematopoietic stem cells (ifHSCs) might be suitable for IUHSCT, and should be seriously evaluated.\",\"PeriodicalId\":90831,\"journal\":{\"name\":\"Gene technology\",\"volume\":\"9 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470128/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gene technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gene technology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

骨髓移植(BMT)或造血干细胞移植(HSCT)是细胞治疗的一种原型。然而，迄今为止，BMT仍然存在一些并发症。最近的技术进步鼓励我们考虑传统BMT的替代方案。具体来说，我们提出子宫内HSCT (IUHSCT)。为此，我们建议诱导胎儿样造血干细胞(ifhsc)可能适合IUHSCT，并应认真评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Genetic Engineering to Induce Fetal-Like Hematopoietic Stem Cells.

本刊更多论文

Genetic Engineering to Induce Fetal-Like Hematopoietic Stem Cells.

Bone marrow transplantation (BMT) or hematopoietic stem cell transplantation (HSCT) is an archetype of cellular therapy. However, to date BMT still suffers from several complications. Recent technological advances have encouraged us to think about an alternative to traditional BMT. Specifically, we propose in utero HSCT (IUHSCT). For this purpose, we suggest that induced fetal-like hematopoietic stem cells (ifHSCs) might be suitable for IUHSCT, and should be seriously evaluated.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Gene technology

自引率

0.00%

发文量